白血球分離術的全球市場

Leukapheresis

出版日期: 2024年09月02日 | 出版商:

Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球白血球分離療法市場預計將達到 1.437 億美元

全球白血球分離療法市場預計 2023 年為 8,970 萬美元，預計到 2030 年將達到 1.437 億美元，在 2023-2030 年分析期間複合年成長率為 7.0%。白血球分離設備是本報告分析的細分市場之一，複合年成長率為 7.1%，預計到分析期結束時將達到 1.226 億美元。分析期間，拋棄式白血球分離術領域的複合年成長率預計為 6.0%。

美國市場預估成長2,460萬美元，中國複合年成長率為6.5%

預計 2023 年美國白血球分離術市場規模將達 2,460 萬美元。中國作為全球第二大經濟體，預計2030年市場規模將達2,220萬美元，2023-2030年分析期間複合年成長率為6.5%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間複合年成長率分別為 6.7% 和 5.6%。在歐洲，德國預計複合年成長率為 5.8%。

全球白血球去除療法市場—主要趨勢和促進因素總結

什麼是白血球去除術以及為什麼它在治療中變得越來越重要？

白血球去除術是一種選擇性地從血液中去除白血球（白血球）的醫療程序，並且擴大用於治療多種疾病，包括白血病、多發性骨髓瘤和自體免疫疾病。它擴大用於治療多種疾病，包括白血病、多發性骨髓瘤和自體免疫疾病。這種方法越來越重要，因為它在治療和研究環境中都發揮著重要作用。在治療應用中，白血球去除術用於減少患有某些類型癌症的患者中危險的高白血球計數。在研究中，它用於收集白血球，用於開發和測試 CAR-T 細胞療法等新治療方法。隨著對先進治療方案的需求不斷增加，白血球去除術正成為醫療領域的重要工具。

技術進展如何影響白血球分離術市場？

技術進步在白血球分離術市場的成長中發揮重要作用。更有效率、自動化的單採設備的開發使手術過程更安全、更快速、對患者更舒適。這些進步也使得白血球產量更高，這對於 CAR-T 細胞療法等治療的成功尤其重要。此外，白血球分離療法的創新正在降低併發症的風險並改善患者的治療結果。隨著技術的不斷發展，預計白血球分離療法的功效和可及性將進一步提高並在臨床和研究環境中得到採用。

白血球去除術在推動癌症治療中扮演什麼角色？

白血球分離術在癌症治療的進展中發揮關鍵作用，特別是在 CAR-T 細胞療法等免疫療法的開發中。這種治療方法使用白血球分離術從患者血液中去除 T 細胞，並對它們進行基因改造，以瞄準並摧毀癌細胞。這種個人化的癌症治療方法已顯示出有希望的結果，特別是對於患有某些類型的白血病和淋巴瘤的患者。此類治療方法的日益成功增加了對白血球分離術的需求，白血球分離術是治療過程中的關鍵步驟。隨著更多免疫療法的開發和核准，白血球分離術的使用預計將擴大並成為未來癌症治療的重要組成部分。

推動白血球分離術市場成長的因素有哪些？

白血球分離術市場的成長是由多種因素推動的，例如癌症和自體免疫疾病盛行率的增加、血漿分離術技術的進步以及對個人化醫療的需求不斷成長。另一個主要促進因素是擴大採用免疫療法，這種療法利用白血球分離術來收穫免疫細胞。此外，以開發新治療方法為重點的臨床試驗和研究活動的擴展正在推動對白血球分離手術的需求。隨著醫學界不斷探索新治療方法並改進現有治療方法，白血球去除療法市場預計將持續成長，因為它在現代醫學的進步中發揮著重要作用。

受訪企業範例（共12家）

Allcells LLC
Asahi Kasei Medical Co., Ltd.
BioIVT
Caltag Medsystems Limited
Fresenius SE & Co. KGaA
Haemonetics Corporation
HemaCare Corporation
Key Biologics, LLC.
MacoPharma SA
Ppa Research Group, Inc.
Precision Medicine Group, Inc.
StemCell Technologies Inc.
StemExpress
Terumo BCT, Inc.
Zenbio, Inc.

The global market for Leukapheresis estimated at US$89.7 Million in the year 2023, is expected to reach US$143.7 Million by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Leukapheresis Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$122.6 Million by the end of the analysis period. Growth in the Leukapheresis Disposables segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$24.6 Million While China is Forecast to Grow at 6.5% CAGR

The Leukapheresis market in the U.S. is estimated at US$24.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$22.2 Million by the year 2030 trailing a CAGR of 6.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Leukapheresis Market - Key Trends & Drivers Summarized

What Is Leukapheresis and Why Is It Gaining Importance in Medical Treatments?

Leukapheresis is a medical procedure that involves the selective removal of white blood cells (leukocytes) from the blood, which is increasingly being used in the treatment of various diseases, including leukemia, multiple myeloma, and autoimmune disorders. This procedure is gaining importance due to its critical role in both therapeutic and research settings. In therapeutic applications, leukapheresis is used to reduce high white blood cell counts, which can be dangerous in certain cancer patients. In research, it is employed to collect leukocytes for use in developing and testing new therapies, such as CAR-T cell therapy. As the demand for advanced treatment options grows, leukapheresis is becoming an essential tool in the medical field.

How Are Technological Advancements Impacting the Leukapheresis Market?

Technological advancements are playing a significant role in the growth of the leukapheresis market. The development of more efficient and automated apheresis machines has made the procedure safer, faster, and more comfortable for patients. These advancements are also enabling higher yields of leukocytes, which is particularly important for the success of therapies like CAR-T cell therapy. Additionally, innovations in leukapheresis techniques are reducing the risk of complications and improving patient outcomes. As technology continues to evolve, it is expected to further enhance the efficacy and accessibility of leukapheresis, driving its adoption in both clinical and research settings.

What Role Does Leukapheresis Play in the Advancement of Cancer Therapies?

Leukapheresis is playing a crucial role in the advancement of cancer therapies, particularly in the development of immunotherapies such as CAR-T cell therapy. In this process, leukapheresis is used to collect T cells from the patient’s blood, which are then genetically modified to target and destroy cancer cells. This personalized approach to cancer treatment has shown promising results, especially in patients with certain types of leukemia and lymphoma. The increasing success of these therapies is driving demand for leukapheresis, as it is a critical step in the treatment process. As more immunotherapies are developed and approved, the use of leukapheresis is expected to expand, making it a key component in the future of cancer treatment.

What Factors Are Driving the Growth of the Leukapheresis Market?

The growth in the leukapheresis market is driven by several factors, including the increasing prevalence of cancer and autoimmune diseases, advancements in apheresis technology, and the rising demand for personalized medicine. The growing adoption of immunotherapies, which rely on leukapheresis for the collection of immune cells, is also a significant driver. Additionally, the expansion of clinical trials and research activities focused on developing new treatments is boosting the demand for leukapheresis procedures. As the medical community continues to explore new therapeutic applications and improve existing ones, the leukapheresis market is expected to experience sustained growth, driven by its critical role in advancing modern medical treatments.

Select Competitors (Total 12 Featured) -

Allcells LLC
Asahi Kasei Medical Co., Ltd.
BioIVT
Caltag Medsystems Limited
Fresenius SE & Co. KGaA
Haemonetics Corporation
HemaCare Corporation
Key Biologics, LLC.
MacoPharma SA
Ppa Research Group, Inc.
Precision Medicine Group, Inc.
StemCell Technologies Inc.
StemExpress
Terumo BCT, Inc.
Zenbio, Inc.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Leukapheresis - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Advancements in Apheresis Technology Propel Adoption of Leukapheresis in Therapeutic Applications
- Shift Towards Personalized Medicine Expands Addressable Market for Leukapheresis
- Rising Focus on Cell-Based Therapies and Immunotherapy Drives Adoption in Cancer Treatment
- Rising Importance of Leukapheresis in Bone Marrow Transplantation Strengthens Demand
- Growing Application of Leukapheresis in Stem Cell Collection Strengthens Market Demand
- Technological Innovations in Leukapheresis Devices Enhance Efficiency and Patient Comfort
- Expanding Use of Leukapheresis in Hematology and Oncology Generates New Opportunities
- Push for High-Purity Cell Collection Fuels Demand in Clinical and Research Settings
- Increasing Adoption of Leukapheresis in CAR-T Cell Therapy Accelerates Market Expansion
- Technological Advancements in Automated and Continuous Flow Systems Expand Market Potential
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Therapeutic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Blood Component Providers & Blood Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Blood Component Providers & Blood Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Blood Component Providers & Blood Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 11: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 12: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 13: World Leukapheresis Market Analysis of Annual Sales in US$ for Years 2014 through 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Leukapheresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 15: World Historic Review for Leukapheresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 16: World 16-Year Perspective for Leukapheresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 18: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 19: World 16-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 21: World Historic Review for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 22: World 16-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 24: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 25: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Hospital & Transfusion Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 27: World Historic Review for Hospital & Transfusion Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 28: World 16-Year Perspective for Hospital & Transfusion Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 29: USA Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 30: USA Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 31: USA 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
- TABLE 32: USA Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 33: USA Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 34: USA 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
- TABLE 35: USA Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 36: USA Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 37: USA 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
CANADA
- TABLE 38: Canada Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 39: Canada Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 40: Canada 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
- TABLE 41: Canada Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 42: Canada Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 43: Canada 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
- TABLE 44: Canada Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 45: Canada Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 46: Canada 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
JAPAN
- Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 47: Japan Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 48: Japan Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 49: Japan 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
- TABLE 50: Japan Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 51: Japan Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 52: Japan 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
- TABLE 53: Japan Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 54: Japan Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 55: Japan 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
CHINA
- Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 56: China Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 57: China Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 58: China 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
- TABLE 59: China Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 60: China Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 61: China 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
- TABLE 62: China Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 63: China Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 64: China 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
EUROPE
- Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 65: Europe Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 66: Europe Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 67: Europe 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
- TABLE 68: Europe Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 69: Europe Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 70: Europe 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
- TABLE 71: Europe Recent Past, Current & Future Analysis for Leukapheresis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 72: Europe Historic Review for Leukapheresis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 73: Europe 16-Year Perspective for Leukapheresis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 74: Europe Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 75: Europe Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 76: Europe 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
FRANCE
- Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 77: France Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 78: France Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 79: France 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
- TABLE 80: France Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 81: France Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 82: France 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
- TABLE 83: France Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 84: France Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 85: France 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
GERMANY
- Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 86: Germany Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 87: Germany Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 88: Germany 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
- TABLE 89: Germany Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 90: Germany Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 91: Germany 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
- TABLE 92: Germany Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 93: Germany Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 94: Germany 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
ITALY
- TABLE 95: Italy Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 96: Italy Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 97: Italy 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
- TABLE 98: Italy Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 99: Italy Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 100: Italy 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
- TABLE 101: Italy Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 102: Italy Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 103: Italy 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 104: UK Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 105: UK Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 106: UK 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
- TABLE 107: UK Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 108: UK Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 109: UK 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
- TABLE 110: UK Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 111: UK Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 112: UK 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 114: Rest of Europe Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 115: Rest of Europe 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
- TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 117: Rest of Europe Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 118: Rest of Europe 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
- TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 120: Rest of Europe Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 121: Rest of Europe 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 123: Asia-Pacific Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 124: Asia-Pacific 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
- TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 126: Asia-Pacific Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 127: Asia-Pacific 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
- TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 129: Asia-Pacific Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 130: Asia-Pacific 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
REST OF WORLD
- TABLE 131: Rest of World Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 132: Rest of World Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 133: Rest of World 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
- TABLE 134: Rest of World Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 135: Rest of World Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 136: Rest of World 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
- TABLE 137: Rest of World Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 138: Rest of World Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 139: Rest of World 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030